CAGRISEMA

CAGRISEMA

$69.00

USD

Research Use Only (RUO) • Not for Human or Veterinary Use • Not for Consumption.

CAGRISEMA (CagriSema) is a research-grade dual-peptide blend combining Cagrilintide and Semaglutide, supplied exclusively for in-vitro and non-clinical laboratory research. This cagrilintide semaglutide blend is commonly referenced in mechanistic workflows exploring GLP-1 receptor signaling, amylin receptor pathway research, and incretin–amylin dual-pathway interactions under controlled experimental conditions.

Clarification: This product is a research blend (not a pharmaceutical, supplement, or consumer product). It is not approved for human consumption, injection, supplementation, cosmetic use, diagnostic use, or veterinary administration.

What Is CagriSema (Cagrilintide + Semaglutide) Research Blend?

In laboratory context, Semaglutide is widely referenced as a GLP-1 receptor agonist research tool, while Cagrilintide is referenced as a long-acting amylin analogue studied for receptor-complex signaling behavior. A combined blend supports research designs that compare single-pathway vs dual-pathway signaling and assay-linked readouts in controlled models.

Dual Pathway Research Context – GLP-1 Receptor + Amylin/Calcitonin Receptor Systems

This dual agonist research peptide blend is typically discussed in relation to receptor binding, signal transduction, and downstream pathway activation within neuroendocrine and metabolic research models. Any mention of pathways is strictly for scientific context and does not imply clinical outcomes.

Key Features – Research Grade Quality, Traceability & Documentation

  • Dual-peptide formulation: Cagrilintide + Semaglutide for GLP-1 and amylin pathway modeling
  • Purity focus: ≥99% purity with HPLC verification (batch-based)
  • Lyophilized format: supplied as lyophilized white powder for research workflow practicality
  • CoA support: Certificate of Analysis available upon request for qualified labs
  • Traceability: lot-level documentation aligned with reproducible research practices

Technical Specifications – CAGRISEMA Research Peptide Blend (RUO)

Product Name CAGRISEMA (CagriSema)
Blend Components Cagrilintide + Semaglutide
Component Keywords Cagrilintide acetate; Semaglutide acetate (batch-dependent)
Component CAS (Reference) 1415456-99-3 (Cagrilintide); 910463-68-2 (Semaglutide)
Form Lyophilized white powder
Purity ≥99% (HPLC verified)
Solubility Compatible with commonly used laboratory-grade aqueous solvents (protocol-dependent)
Storage Store cold, dry, and protected from light per laboratory SOP and stability protocol
Documentation CoA available upon request (qualified laboratories)
Grade Research Use Only (RUO)

Common Research Applications – Receptor Binding, Signaling & Pathway Modeling (Non-Clinical)

  • Receptor binding & interaction studies: GLP-1 receptor / amylin receptor complex investigations (assay-dependent)
  • Signal transduction research: downstream pathway mapping in controlled cellular systems
  • Neuroendocrine signaling models: appetite-related signaling endpoints in non-clinical research context
  • Gastric emptying & transit models: protocol-defined GI kinetics readouts (research context only)
  • Glucose homeostasis readouts: pathway-linked metabolic assay endpoints in controlled models
  • Comparative peptide research: structured comparisons vs other metabolic research peptides (protocol-dependent)

Handling & Storage – Laboratory Guidelines (RUO)

  • Use sterile technique, appropriate PPE, and follow institutional laboratory SOPs
  • Minimize moisture exposure and keep the vial sealed when not in use
  • Prepare solutions only according to protocol requirements using an appropriate sterile solvent/buffer (assay-dependent)
  • Aliquot where appropriate to reduce variability and avoid repeated freeze–thaw cycles

Why Researchers Source from Peptides Skin – B2B Supply, CoA & Traceability

  • Analytical transparency: batch testing support and documentation workflows
  • CoA availability: HPLC-linked purity reporting on request for qualified institutions
  • Secure fulfillment: handling and shipping practices designed to protect reagent integrity

FAQs – CAGRISEMA (Cagrilintide + Semaglutide) Research Blend

What is CAGRISEMA (CagriSema) peptide?

CAGRISEMA (also referenced as CagriSema) is a dual-peptide research blend combining Cagrilintide and Semaglutide for in-vitro and non-clinical research workflows.

Is CAGRISEMA for human use, injection, or supplementation?

No. This product is supplied strictly as Research Use Only (RUO) and is not approved for human consumption, injection, supplementation, cosmetic use, diagnostic use, or veterinary administration.

What pathways are studied with Cagrilintide + Semaglutide blends?

In research context, blends are commonly discussed for GLP-1 receptor pathway and amylin receptor complex investigations, including receptor binding, signaling, and pathway-level readouts in controlled models (assay-dependent).

Does CAGRISEMA have a single CAS number?

As a multi-component blend, it may not map to one unique CAS for the entire formulation. Component CAS references are often listed for traceability (e.g., 1415456-99-3 for Cagrilintide and 910463-68-2 for Semaglutide). Always rely on batch documentation.

Is a Certificate of Analysis (CoA) available for this research blend?

Yes. A batch-specific CoA is available upon request for qualified laboratories and research institutions.

How should lyophilized CAGRISEMA be stored in a lab?

Store cold, sealed, dry, and protected from light according to your laboratory stability protocol and SOP. After preparation, minimize variability by avoiding repeated freeze–thaw cycles and following sterile technique.

RESEARCH USE ONLY (RUO):
For laboratory research and development purposes only. Not a drug, supplement, or food. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Any mention of biological pathways refers exclusively to controlled research models.